Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 2
2010 2
2011 2
2012 3
2013 2
2014 2
2015 1
2017 2
2018 4
2019 3
2021 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

26 results

Results by year

Filters applied: . Clear all
Page 1
Deep immune profiling reveals targetable mechanisms of immune evasion in immune checkpoint inhibitor-refractory glioblastoma.
Simonds EF, Lu ED, Badillo O, Karimi S, Liu EV, Tamaki W, Rancan C, Downey KM, Stultz J, Sinha M, McHenry LK, Nasholm NM, Chuntova P, Sundström A, Genoud V, Shahani SA, Wang LD, Brown CE, Walker PR, Swartling FJ, Fong L, Okada H, Weiss WA, Hellström M. Simonds EF, et al. J Immunother Cancer. 2021 Jun;9(6):e002181. doi: 10.1136/jitc-2020-002181. J Immunother Cancer. 2021. PMID: 34083417 Free PMC article.
Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma.
du Chatinier A, Meel MH, Das AI, Metselaar DS, Waranecki P, Bugiani M, Breur M, Simonds EF, Lu ED, Weiss WA, Garcia Vallejo JJ, Hoving EW, Phoenix TN, Hulleman E. du Chatinier A, et al. Among authors: simonds ef. Neurooncol Adv. 2022 May 24;4(1):vdac079. doi: 10.1093/noajnl/vdac079. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 35733514 Free PMC article.
Pediatric high-grade glioma: biologically and clinically in need of new thinking.
Jones C, Karajannis MA, Jones DTW, Kieran MW, Monje M, Baker SJ, Becher OJ, Cho YJ, Gupta N, Hawkins C, Hargrave D, Haas-Kogan DA, Jabado N, Li XN, Mueller S, Nicolaides T, Packer RJ, Persson AI, Phillips JJ, Simonds EF, Stafford JM, Tang Y, Pfister SM, Weiss WA. Jones C, et al. Among authors: simonds ef. Neuro Oncol. 2017 Feb 1;19(2):153-161. doi: 10.1093/neuonc/now101. Neuro Oncol. 2017. PMID: 27282398 Free PMC article. Review.
GateFinder: projection-based gating strategy optimization for flow and mass cytometry.
Aghaeepour N, Simonds EF, Knapp DJHF, Bruggner RV, Sachs K, Culos A, Gherardini PF, Samusik N, Fragiadakis GK, Bendall SC, Gaudilliere B, Angst MS, Eaves CJ, Weiss WA, Fantl WJ, Nolan GP. Aghaeepour N, et al. Among authors: simonds ef. Bioinformatics. 2018 Dec 1;34(23):4131-4133. doi: 10.1093/bioinformatics/bty430. Bioinformatics. 2018. PMID: 29850785 Free PMC article.
Switchable assembly and function of antibody complexes in vivo using a small molecule.
Martinko AJ, Simonds EF, Prasad S, Ponce A, Bracken CJ, Wei J, Wang YH, Chow TL, Huang Z, Evans MJ, Wells JA, Hill ZB. Martinko AJ, et al. Among authors: simonds ef. Proc Natl Acad Sci U S A. 2022 Mar 1;119(9):e2117402119. doi: 10.1073/pnas.2117402119. Proc Natl Acad Sci U S A. 2022. PMID: 35210365 Free PMC article.
A Kinase Inhibitor Targeted to mTORC1 Drives Regression in Glioblastoma.
Fan Q, Aksoy O, Wong RA, Ilkhanizadeh S, Novotny CJ, Gustafson WC, Truong AY, Cayanan G, Simonds EF, Haas-Kogan D, Phillips JJ, Nicolaides T, Okaniwa M, Shokat KM, Weiss WA. Fan Q, et al. Among authors: simonds ef. Cancer Cell. 2017 Mar 13;31(3):424-435. doi: 10.1016/j.ccell.2017.01.014. Cancer Cell. 2017. PMID: 28292440 Free PMC article.
26 results